HERO MOTOCORP Surges by 6%; BSE AUTO Index Down 3.1%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  •
  • MyStocks
MEMBER'S LOGIN

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

HERO MOTOCORP Surges by 6%; BSE AUTO Index Down 3.1%
Thu, 19 Mar 02 pm

HERO MOTOCORP share price has zoomed 6% and is presently trading at Rs 1,782.

Meanwhile, the BSE AUTO Index is at 12,115 (down 3.1%).

Among the top Gainers in the BSE AUTO Index today are HERO MOTOCORP (up 5.6%) and BAJAJ AUTO (up 7.7%).

APOLLO TYRES (down 0.3%) and EICHER MOTOR (down 1.2%) are among the top losers today.

Over the last one year, HERO MOTOCORP has moved down from Rs 2,672 to Rs 1,782, registering a loss of Rs 889 (down 33.5%).

On the other hand, the BSE AUTO has moved down from 19,428 to 12,115, loss of 7,313 points (down 37.9%) during the last 12 months.

The top gainers among the BSE AUTO Index stocks during this same period were MRF LTD. (up 0.9%).

One Stock Crorepati: The Biggest Money-Making Opportunity Available Right Now

What About the Benchmark Indices?

The BSE Sensex is at 28,672 (down 0.9%).

The top gainers among the BSE Sensex stocks today are BAJAJ AUTO (up 7.7%), HERO MOTOCORP (up 5.6%) and ITC (up 4.4%). Other gainers include BHARTI AIRTEL (up 4.2%) and POWER GRID (up 4.1%). The most traded stocks in the BSE Sensex are ITC and ICICI BANK.

In the meantime, NSE Nifty is at 8,504 (up 0.1%). The top gainers in the NSE Nifty include BAJAJ AUTO (up 8.7%), ITC (up 5.6%) and BHARTI AIRTEL (up 5.5%). Other gainers include HERO MOTOCORP (up 5.2%) and POWER GRID (up 4.9%) are among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved down from 38,095 to 28,672, registering a loss of 9,423 points (down 24.91%).

HERO MOTOCORP Financial Update...

HERO MOTOCORP net profit stood at Rs 9 billion for the quarter ended December 2019, compared to a profit of Rs 8 billion a year ago. Net Sales declined 11.0% to Rs 70.0 billion during the period as against Rs 78.6 billion in October-December 2018.

For the year ended March 2019, HERO MOTOCORP reported 7.3% decrease in net profit to Rs 34.1 billion compared to net profit of Rs 36.7 billion during FY18.

Revenue of the company grew 2.6% to Rs 340 billion during FY19.

The current Price to earnings ratio of HERO MOTOCORP, based on rolling 12 month earnings, stands at 9.5x.

Archives

RSS RSS



What else is happening in the markets today? Dig in...

Advertisement
FREE Guide for You: Find the Next Crorepati Stock in this Futuristic Industry
Tanushree Banerjee, the co-head of research, just shared her latest guide: 'Find the Next Crorepati Stock in this Futuristic Industry' And she has agreed to make it available for free for a limited time. If you've not claimed your free copy, then do so now. It might not remain free for long. Click Here to Download the Guide

Equitymaster requests your view! Post a comment on "HERO MOTOCORP Surges by 6%; BSE AUTO Index Down 3.1%". Click here!

  

Stock Market Updates

TORRENT PHARMA Surges by 6%; BSE HEALTHCARE Index Up 5.3% (Today's Market)

Apr 7, 2020 10:18 AM

TORRENT PHARMA share price has surged by 6% and its current market price is Rs 2,214. The BSE HEALTHCARE is up by 5.3%. The top gainers in the BSE HEALTHCARE Index are TORRENT PHARMA (up 5.8%) and SANOFI INDIA (up 6.0%). The top losers is GSK PHARMA (down 0.4%).

SUN PHARMA ADV. RES. Surges by 11%; BSE 500 Index Up 3.9% (Today's Market)

Apr 7, 2020 10:16 AM

SUN PHARMA ADV. RES. share price has surged by 11% and its current market price is Rs 117. The BSE 500 is up by 3.9%. The top gainers in the BSE 500 Index are SUN PHARMA ADV. RES. (up 11.4%) and LAURUS LABS LTD (up 12.9%). The top losers are SCHAEFFLER INDIA LTD and ITC (down 0.1%).

CADILA HEALTHCARE Surges by 15%; BSE HEALTHCARE Index Up 5.3% (Today's Market)

Apr 7, 2020 10:16 AM

CADILA HEALTHCARE share price has surged by 15% and its current market price is Rs 316. The BSE HEALTHCARE is up by 5.3%. The top gainers in the BSE HEALTHCARE Index are CADILA HEALTHCARE (up 15.0%) and LAURUS LABS LTD (up 12.9%). The top losers is GSK PHARMA (down 0.4%).

PROCTER & GAMBLE HEALTH Surges by 6%; BSE HEALTHCARE Index Up 5.3% (Today's Market)

Apr 7, 2020 10:16 AM

PROCTER & GAMBLE HEALTH share price has surged by 6% and its current market price is Rs 4,098. The BSE HEALTHCARE is up by 5.3%. The top gainers in the BSE HEALTHCARE Index are PROCTER & GAMBLE HEALTH (up 5.6%) and SANOFI INDIA (up 6.0%). The top losers is GSK PHARMA (down 0.4%).

PFIZER Surges by 7%; BSE HEALTHCARE Index Up 5.3% (Today's Market)

Apr 7, 2020 10:16 AM

PFIZER share price has surged by 7% and its current market price is Rs 4,340. The BSE HEALTHCARE is up by 5.3%. The top gainers in the BSE HEALTHCARE Index are PFIZER (up 6.7%) and SANOFI INDIA (up 6.0%). The top losers is GSK PHARMA (down 0.4%).

Sensex Opens Over 1,200 Points Higher; Banking Stocks Rally (Today's Market)

Apr 7, 2020 09:30 am

Asian stock markets are higher today as Chinese and Hong Kong shares show gains. The Shanghai Composite is up 1.7% while the Hang Seng is up 0.6%.

View More Indian Share Market News

Most Popular

Sorry Warren Buffett, I'm Following This Man Instead of You in 2020(The 5 Minute Wrapup)

Mar 30, 2020

This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...

The Biggest Trading Opportunity of 2020 is Here...

Mar 26, 2020

India's #1 trader, Vijay Bhambwani, talks about a hugely profitable trading opportunity which you must know about today!

A Big Trading Opportunity is Coming Your Way Soon(Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

One Stock that is All Charged Up for the Post Coronavirus Rebound(The 5 Minute Wrapup)

Apr 1, 2020

A stock with strong moat is currently trading near 5-year lows.

The Insiders See a Buying Opportunity in These Smallcaps Amid Coronavirus Outbreak(Profit Hunter)

Mar 31, 2020

The promoters are buying these smallcaps amid the coronavirus outbreak.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

How to Trade the Coronavirus Crash - Download this FREE Report Now
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
Free Report: The Secret to Increasing Your Trading Profits Daily!
Find Out Our Top 7 Bluechips for 2020 Virtually FREE. Click Here Now!

S&P BSE SENSEX


Apr 7, 2020 11:51 AM

OTHER USEFUL LINKS

MARKET STATS


ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
APPS
  • Get Equitymaster Android App on Google Play
  • Get Equitymaster iOS App on App Store
FOLLOW

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.